Showing results (221-230 of 237) with videos related to
Sort By:
Pageof 24
ACS Medicinal Chemistry Letters|June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β InhibitorsHongyi Yu, Michael L Moore, Karl Erhard, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrasePan F Chan, Thomas Germe, Benjamin D Bax, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2012
Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitorsRobert M Sanchez, Karl Erhard, Mary Ann Hardwicke, et al.Nature Communications|July 2, 2025
Cooperative and inhibitory ion transport in functionalized angstrom-scale two-dimensional channelsMingzhan Wang, Qinsi Xiong, Xiaolin Yue, et al.Bioorganic & Medicinal Chemistry Letters|April 10, 2019
Structure-guided design of antibacterials that allosterically inhibit DNA gyraseReema K Thalji, Kaushik Raha, Daniele Andreotti, et al.Bioorganic & Medicinal Chemistry Letters|February 25, 2012
Synthesis and structure-activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitorsHong Lin, Karl Erhard, Mary Ann Hardwicke, et al.Chemical Reviews|May 12, 2021
Quantum Chemistry Calculations for MetabolomicsRicardo M Borges, Sean M Colby, Susanta Das, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBSHilary Schenck Eidam, John Russell, Kaushik Raha, et al.Chemical Society Reviews|July 2, 2021
A critical overview of computational approaches employed for COVID-19 drug discoveryEugene N Muratov, Rommie Amaro, Carolina H Andrade, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta InhibitorsHong Lin, Mark J Schulz, Ren Xie, et al.Pageof 24